产品特点
Revised: September 2010
AN: 00678/2010
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
HyperCard 10 mg Coated Tablets for Cats
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains:
Active substance
Diltiazem
EXCIPIENTS
Tartrazine (E102)
Titanium dioxide, (E171)
For a full list of excipients, see
section 6.1.
Quantitative composition
9.20 mg (equivalent to 10 mg of
Diltiazem hydrochloride)
0.11 mg
1.1 mg
3.
PHARMACEUTICAL FORM
Coated tablet.
A yellow coated biconvex tablet.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cats.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the therapeutic treatment of feline primary hypertrophic cardiomyopathy.
4.3
CONTRAINDICATIONS
Do not use in animals suffering from AV block (2
nd
or 3
rd
), hypotension or sick
sinus syndrome.
Diltiazem should not be given to animals suffering from hepatic disease.
Do not use in animals suffering from renal disease.
Do not use in cats less than 12 months old.
Do not use in cats weighing less than 3 kg.
Do not use in animals that are hypersensitive to Diltiazem.
Do not use in cats with severe bradycardia or arterial hypotension.
Do not use in conjunction with
blockers, digitalis or digoxin.
Do not use in pregnant or lactating females.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
Revised: September 2010
AN: 00678/2010
Page 2 of 5
4.5
SPECIAL PRECAUTIONS FOR USE
i. Special precautions for use in animals
Hepatic failure may increase the plasma concentra
阅读完整的文件
产品特点 